Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Novel fusion protein PK5-RL-Gal-3C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity

Fig. 1

Preparation of recombinant protein PK5, Gal-3C, and PK5-RL-Gal-3C. A Schematic structure of full-length Gal-3, PK5, Gal-3C, and PK5-RL-Gal-3C. B Purity of recombinant proteins was analyzed by using 15% SDS-PAGE. rPK5 is composed of 80 amino acid residues with 6 × His tag at its N-terminus for purification. rGal-3C contains 107 to 250 amino acid residues of full-length Gal-3. RL is composed of 12 amino acids (AEAAAKEAAAKA)

Back to article page